BEAM vs OKE · rev $63.5M vs P/E 15, rev $21.70B
Beam Therapeutics Inc (BEAM) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
BEAM currently screens at market cap $2.01B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the BEAM and OKE stock pages for the full models.
Not investment advice.